Mark A. Geyer

Distinguished Professor of Psychiatry and Neurosciences Emeritus at the University of California San Diego,where he directs the Neuropsychopharmacology Unit of the VISN 22 Veterans Administration Mental Illness Research, Clinical, and Education Center.

Dr. Geyer is a true innovator in the field of the psychedelics. In 1993, he co-founded the Heffter Research Institute, which pioneered and supported much of the scientific research that has prompted the exploration of psychedelics as potential therapeutics in humans. His research focuses on developing parallel behavioral paradigms in animals and humans for use in psychiatric drug discovery. He recently co-founded the Psychedelics and Health Research Initiative at UCSD, which is exploring the efficacy of psychedelics in the treatment of pain disorders.

Dr. Geyer is respected internationally for his research on the psychophysiology, neurobiology, and pharmacotherapy of schizophrenia and bipolar disorder. He has published more than 470 peer-reviewed papers and over 50 reviews.